This is a synthetic peptide designed for use in combination with anti- COL4A5 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
COL4A5
Reaktivität: Human, Maus
Wirt: Synthetic
BP
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
COL4a5 (COL4A5)
(Collagen, Type IV, alpha 5 (COL4A5))
Synonyme
ASLN Peptide, ATS Peptide, CA54 Peptide, RGD1565499 Peptide, col4a5 Peptide, fj65e07 Peptide, im:7157877 Peptide, si:ch211-174g17.1 Peptide, wu:fj65e07 Peptide, collagen type IV alpha 5 chain Peptide, collagen, type IV, alpha 5 Peptide, collagen, type IV, alpha 1 Peptide, COL4A5 Peptide, Col4a5 Peptide, col4a1 Peptide, LOC100285389 Peptide
Hintergrund
This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene.